Cme (CME) Cost of Revenue (2009 - 2026)

Cme (CME) has reported Cost of Revenue for 18 consecutive years, with $59.9 million the latest figure, recorded in Q2 2026.

• Quarterly Cost of Revenue rose 12.59% year-over-year to $59.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $253.4 million (down 2.61% YoY) and the FY2025 annual result came in at $248.5 million, down 7.14% from the prior year.
• Cost of Revenue grew to $59.9 million in Q2 2026 per CME's latest filing, from $52.5 million in the prior quarter.
• Over the last five years, Cost of Revenue for CME reached as high as $101.9 million in Q4 2023 and fell as low as $43.9 million in Q3 2022.
• A 5-year average of $63.7 million and a median of $57.0 million in 2023 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2023 — Cost of Revenue climbed 28.7% — and 2025, when it slipped 11.56%.
• Year by year, Cost of Revenue stood at $95.0 million in 2022, then advanced by 7.26% to $101.9 million in 2023, then slipped by 11.29% to $90.4 million in 2024, then dropped by 4.98% to $85.9 million in 2025, then slumped by 30.27% to $59.9 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $59.9 million, $52.5 million, and $85.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.